Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interscalene Block and Dysfunction Diaphragmatic: Effect of Low Volume of Ropivacaine 0,1%
NCT04173364Phase 3Completed
- Sponsor
- CHU de Lille
- Start
- Oct 2019
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in postoperative pain, sponsored by CHU de Lille. Started Oct 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04173364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04173364.